Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow-Up Study to Demonstrate the Safety and Performance of the PRESERFLO™ MicroShunt XI in Patients With Primary Open Angle Glaucoma

NCT07235592 is registered in ClinicalTrials.gov with Santen SAS as lead sponsor.

NCT NCT07235592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07235592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow-Up Study to Demonstrate the Safety and Performance of the PRESERFLO™ MicroShunt XI in Patients With Primary Open Angle Glaucoma
Lead sponsor
Santen SAS
Phase
Observational
Overall status
Recruiting
Start date
March 19, 2026
Completion date
September 30, 2027
Enrollment
112 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma